Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II/III study of TTP273 for the treatment of type 2 diabetes.

Trial Profile

Phase II/III study of TTP273 for the treatment of type 2 diabetes.

Planning
Phase of Trial: Phase II/III

Latest Information Update: 19 Jun 2018

At a glance

  • Drugs TTP 273 (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Jun 2018 New trial record
    • 12 Jun 2018 audit According to the vTv Therapeutics LLC media release, company will is planning this trial in China and other Pacific Rim countries pursuant to a license agreement with Huadong Medicine.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top